Early Adversity and the Immune Hypothesis: Call for a Dialogue between Basic and Clinical Neuroscience
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 16249
Special Issue Editors
Interests: early adversity; microglia; neuroinflammation; microbiome; psychopathology
Interests: early adversity; systemic inflammation; developmental psychopathology; adolescence; depression
Interests: early adversity; microglia; neuroinflammation; microbiome; psychopathology
Special Issue Information
Dear Colleagues,
A growing body of work has implicated the immune system in mediating key developmental, cognitive, and behavioral outcomes associated with early adversity. In this Special Issue, we seek input from preclinical and clinical researchers to assess current progress, challenges, and unresolved questions. Topics of particular interest include ways to improve cross talk between preclinical and clinical studies, the unbiased search for peripheral and central immune mediators (beyond cytokines), advantages and limitations of current animal models, the gut microbiome and brain–blood barrier dysregulation as potential key players, sex differences, imaging microglial activity and neuroinflammation, and therapeutic implications.
Dr. Arie Kaffman
Dr. Kate Ryan Kuhlman
Dr. Bridget L. Callaghan
Dr. Christine Heim
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- early adversity
- microglia
- neuroinflammation
- microbiome
- psychopathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.